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ABSTRACT 
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Tuberculosis is an old new problem. In the beginning of the 20th century TB was 
responsible for deaths of tens of thousands of Finns. After discovering the 
medications the situation improved substantially and in the 1970s the 
prevalence of TB was only 70 new cases per 100 000 inhabitants in Finland. 
Today the threat of TB is rising: tuberculosis is reawakening due to immigrants 
from high prevalence countries. These people are from all ages, including fertile 
women who plan pregnancy or are already pregnant. Measures must be taken 
to prevent spreading of the disease. These women should get information on 
the disease, its symptoms and have the Mantoux test done. Midwifes are in an 
important position in giving the advice and guidance.  
 
This bachelor’s thesis was executed as a literature review on tuberculosis 
particularly on the pulmonary one. Special focus was on gynecology and 
obstetrics aiming to produce a booklet for midwifes and midwifery students. The 
booklet was written in English and Finnish. There is a need for more accurate 
data on the topic. The idea is to update the old information. The booklet is 
meant to help midwifes recognize and prevent spreading of tuberculosis and 
further on educate their patients.  
 
The results crystallize in offering an up-to-date package of essential information 
on TB and its prevention. This information meant especially for midwifes and 
midwifery students will be useful to other health care professionals as well. This 
thesis goes beyond the BCG-vaccine; main focus being in detection and 
prevention of TB. 
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Tuberkuloosi ei ole uusi ongelma. 1900-luvun alussa se oli syynä kymmenien 
tuhansien suomalaisten kuolemaan. Tuberkuloosilääkkeiden keksimisen jälkeen 
tilanne parani huomattavasti ja 1970-luvulla tuberkuloosia esiintyi vain noin 70 
uutta tapausta 100 000 kansalaista kohti. Taudin uhka on jälleen ajankohtainen: 
tuberkuloosi on uudelleenheräämässä taudin suurten riskimaiden 
maahanmuuttajien tullessa Suomeen. Heitä on kaikista ikäluokista, mukaan 
lukien hedelmällisessä iässä olevat naiset, jotka suunnittelevat raskaaksi tuloa 
tai ovat jo raskaana. On ryhdyttävä toimenpiteisiin taudin leviämisen 
ehkäisemiseksi. Näiden maahanmuuttajanaisten tulisi saada tietoa sairaudesta, 
sen oireista ja heidät tulisi testata Mantoux’n ihokokeella. Kätilöt ovat tärkeässä 
asemassa antamassa neuvontaa ja ohjausta. 
 
Tämä opinnäytetyö on kirjallisuuskatsaus tuberkuloosista, erityisesti keuhko-
tuberkuloosista. Työ keskittyy gynekologiaan ja obstetriikkaan tavoitteena 
tuottaa myös sekä englannin- että suomenkielinen opaskirjanen. On tarve 
saada tarkkaa ja tuoretta tietoa tuberkuloosista. Ideana on päivittää vanhat 
tiedot. Opaskirjasen tarkoituksena on auttaa kätilöitä ja kätilöopiskelijoita 
tunnistamaan tuberkuloosi ja ehkäistä sen leviäminen.  
 
Opinnäytetyön tuottama päivitetty tietopaketti antaa tärkeää tietoa 
tuberkuloosista ja sen ehkäisystä. Tämä tietopaketti on tarkoitettu erityisesti 
kätilöopiskelijoille ja kätilöille, mutta on hyödyllinen muillekin terveyden-
huoltoalalla työskenteleville. Opinnäytetyössä keskitytään erityisesti taudin 
havaitsemiseen ja ehkäisyyn. 
 
 
Avainsanoja: tuberkuloosi, gynekologia, obstetriikka, kätilötyö, äitiyshuolto 
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1 INTRODUCTION 
 
 
Tuberculosis (TB) has had a great impact on people in Finland from the 1940s 
to 1950s. It was a common disease among Finns up to the late 1960s. In the 
1970s and 1980s the amount of patients was heavily decreased due to better 
medications. (Hautamäki 2002, 19.) Today tuberculosis raises its head again all 
over the world. In Finland the prevalence of tuberculosis was 7.7 persons per 
100 000 inhabitants in 2009 (THL 2010). This is still little compared to for 
example Russia where in 2007 approximately 110 cases of TB per 100 000 was 
diagnosed. Furthermore, it has been estimated that one in five people have 
latent TB there. (USAID 2009.) 
 
Tuberculosis has been mostly the problem of the undeveloped countries but it is 
coming more prevalent in the developed countries as well. People have almost 
forgotten its existence. The facts and know-how about the disease have 
disappeared within the years passed. This applies, not just the medical 
personnel in general, but also midwifes. Today it is again time to reawake the 
information forgotten. 
  
This thesis discusses tuberculosis both in general and especially from the 
gynecological and obstetrical viewpoint in maternal welfare. The focus is on 
pulmonary tuberculosis which is the most common form of this infection. Every 
year Finland is receiving more and more immigrants from developing countries 
and in general high prevalence TB countries. This work consists of the thesis 
itself as well as of the booklets (in English and Finnish) which summarize the 
work. The booklet is meant for self study material for midwifery students and to 
support midwives in their work. 
 
The thesis continues by stating the purpose, tasks and the objective of the 
study, followed by a survey on its theoretical and functional characteristics. A 
short survey is devoted to a midwife as a counselor. The rest of the thesis is 
organized as follows. We start discussing tuberculosis in general. The disease, 
its history and the current situation are introduced. The rest of the thesis is 
devoted to tuberculosis from the gynecological and obstetrical viewpoints. More 
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specifically, it is concentrated on tuberculosis in pregnancy, childbirth and 
puerperium. Concluding remarks are given in Section 11. 
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2 PURPOSE, TASKS AND OBJECTIVE OF THE THESIS 
 
 
The purpose of this bachelor’s thesis is to prepare a literature review on 
tuberculosis especially from the gynecological and obstetrical viewpoint. The 
focus is on pulmonary tuberculosis which is the most common type. A booklet is 
created based on the review and it summarizes the theory. This booklet will 
offer the information in an understandable way and is written in English and 
Finnish.  
 
Thesis explains facts about the disease, history and current situation. Multi-
resistant tuberculosis and the BCC-vaccination have also been included. 
General facts are followed by tuberculosis in gynecology and obstetrics. The 
chapters are tuberculosis and pregnancy, tuberculosis in childbirth and 
tuberculosis with a breastfeeding mother.  
 
Research questions are: 
 
1. What is tuberculosis and what are its risk factors?  
2. What is its role in gynecology and obstetrics? 
3. How to detect and prevent it from spreading? 
4. What is the role of a midwife in prevention of tuberculosis?  
 
 
The objective of this thesis is to educate midwifery students and support 
midwives in their work to detect tuberculosis and prevent the spreading of this 
disease to pregnant women, other patients and babies. The booklet can 
furthermore enrich the care at maternity wards and clinics.  
 
 
 
 
 
 
 
 8
3 LITERATURE REVIEW AS BACHELOR’S THESIS 
 
 
Literature review can be defined as a theoretical research based on a chosen 
subject. The review creates new information by combining results of previous 
studies on the topic. The objective is to find out from different point of views 
what information there already exits. The links between previous studies are 
explored. Review is concentrated on literature, articles and other publications 
concerning the chosen subject. There has been criticism on literature review 
quality being variable and therefore it is of utmost importance to evaluate the 
reliability and authenticity of the literature used. (Tuomi 2007, 82-83.) 
 
This bachelor’s thesis is a literature review on tuberculosis. The focus is on 
gynecology and obstetrics aiming to produce a guide booklet for midwives and 
midwifery students. Information has been collected from different books, 
Internet, interviews and medical articles. The vast majority is from the year 2005 
or newer updated sources. Special attention is paid to verify the original 
references and their being authentic and trustworthy. The point is to map the 
relevant data from tuberculosis today.  
 
There is a need in midwifery education and to know more about TB, its 
symptoms and prevention in a pregnant woman. This bachelor’s thesis is 
consisted of updated and researched information on TB and it is all of utmost 
importance to know when working in any of the fields of midwifery. The 
research questions and the purpose of the thesis appointed to preparing a 
literature review on this topic.  
 
This bachelor’s thesis has characteristics of theoretical and functional thesis. It 
deepens the special expertise of midwifery students (and midwives) on the topic 
and consequently develops their professional practices and skills.  
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4 A MIDWIFE AS A COUNSELOR 
 
According to Kätilöliitto (2010) a midwife is defined as a person who has 
attended regularly in a midwifery education. This education has to be approved 
in the country and the person must complete it successfully and for by so doing 
has achieved the competence to become certified as a midwife. This 
professional must be able to give care and guidance during pregnancy, 
childbirth and postpartum. A midwife handles deliveries on her own 
responsibility and takes care of the newborn. All this includes preventative 
measures, emergency situations and informing the doctor.  
 
A midwife has an important role in being the entire family’s counselor giving 
health education. A midwife’s own field of work is to promote especially sexual 
and reproductive health including women of all ages. In order to provide good 
midwifery, a midwife must give counseling, offer information and interact in a 
professional way with a client coming from different cultures. (Pienimaa 2007, 
28-29.) A midwife is obligated to follow absolute confidentiality concerning the 
client’s life and medical history. To crystallize, a midwife is a woman’s personal 
counselor, advisor and support. Professional ethics is based on respecting 
human dignity and woman’s right to decide on her own care. (Väyrynen 2007, 
33-35.) 
 
Midwifery is lead by values and principles. They are holistic care, the right to 
self-determination, equality, individualism, safety, and health promotion, 
continuity of care, responsibility, family-orientation and independency. 
(Väyrynen 2007, 35.) A responsible midwife updates her skills and expertise 
continuously. This creates sense of security and trust in the client. (Äimälä 
2007, 39-43.)  
 
The woman is the expert of her own life making choices and decisions based on 
her knowledge and experiences. The midwife provides woman with information 
and advice of her own best expertise with respect to the client. The woman has 
the right to get the information and counseling from the midwife and then decide 
on her own what to do or to choose. This is called an informed choice. It is 
important to share the information in a pleasant atmosphere without any 
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interruptions. Interaction is best when trust and individuality are present in 
counseling. The goal is to create equality and respect between the woman and 
the midwife. A midwife should work for the woman’s own feeling of 
empowerment. This leads to self-determination and self-respect in the client. 
(Äimälä 2007, 39-43.) 
 
A midwife’s role in detection and prevention of tuberculosis is of great 
importance. In maternity clinics the THL’s “BCG-vaccination risk group -inquiry” 
is offered to all expectant mothers. It has been used since the systematic 
vaccinations to all newborns were terminated. This inquiry should be updated to 
cover the parents’ family, work place and closest friends in screening for 
potential infectious TB cases.  
 
A midwife must be alert and aware of TB at all times at all work stations. 
Tuberculosis is reawakening and it could appear under any time of pregnancy, 
delivery or puerperium. Symptoms of TB for non-pregnant persons are normally 
clear, but with pregnant women not easily identified. A midwife must observe 
the mother and the baby for any indications of TB and notify her concerns to the 
physician. During the first months and year the newborn is very prone to 
infections, especially to TB. A midwife must remember this in counseling the 
mother.  
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5 TUBERCULOSIS 
 
 
5.1 What is tuberculosis? 
 
Tuberculosis is an airborne disease caused by mycobacteria. Mycobacterium 
tuberculosis infects humans, whereas Mycobacterium Bovis horned-cattle and 
humans. Both bacteria are included in the Mycobacterium Tuberculosis 
complex which includes also Mycobacterium Africanum and Microti. The bacilli 
are vital and endure drought, cold, acids, bases and several disinfectants. 
However, they are eliminated by boiling water instantly and within 10 minutes in 
70 degrees Celsius. Exposure to direct sunlight does the same. (Kinnula, 
Tukiainen & Laitinen 1997, 465.) 
 
The most common form of tuberculosis is the pulmonary one. The classical 
symptoms are dry, non-productive cough (at an early stage), sputum-like or 
bloody cough (later stage), increased coughing, chest pains, shortness of 
breath, local wheezing cough, general malaise, fatigue, anorexia, weight loss, 
night sweats and low-grade fever. Symptom-free tuberculosis is also a 
possibility at an early stage. Elderly patients have less pronounced symptoms 
than younger patients. (Kinnula et al. 1997, 470; Niederman & Sarosi, 2000; 
Small & Fujiwara 2001; Smeltzer & Bare 2004, 534.)  
 
Assessing and diagnostic findings of tuberculosis include a physical 
examination, complete medical history, tuberculin skin test (Appendix 1.), chest 
x-ray (Appendix 2.), acid-fast bacillus smear and a sputum culture. The x-ray 
reveals lesions in the upper lobes and the smear contains mycobacterium. 
(Smeltzer & Bare 2004, 534.) Tuberculin testing is done, chest x-ray is taken 
and possibly bacteriological studies are made to diagnose TB. Further 
examinations will be carried out at a specific clinic for pulmonary diseases 
where the patient is referred by her physician or gynecologist. Patient who has 
an acute outburst of tuberculosis is to be treated in the specialized hospital or 
unit in isolation. (Maasilta & Salo 2007, 1-3.) 
 
 12
Extra pulmonary forms of tuberculosis are difficult to diagnose. The 
bacteriological examinations usually provide negative results. Other than 
pulmonary manifestations of TB are for instance tuberculosis of the lymph 
nodes. This is the second most common form. The outburst of the disease is 
mostly a reactivation of an old infection. Tuberculosis of the central nervous 
system is an acute emergency. It manifests itself mostly as meningitis. IV 
medications are administered and it is crucial to remember that recovery rate is 
only 20% if patient is unconscious, has fever, convulsions appear and has 
symptoms of paralysis. (Kinnula et al. 1997, 472-475.) 
 
 
5.2 Risk factors 
 
Tuberculosis is infectious, but not especially infectious. It is contagious only 
man to man not via articles. Only the persons who have tuberculosis in the 
lungs or in the larynx and have enough bacteria in their sputum are infecting 
others. (Kinnula et al. 1997, 464.) Bacilli must be at least 10 000-100 000 
pieces in the sputum smear for a person to be infectious. If only the culture is 
positive the risk is minimal. Efficient chemotherapy reduces the number of bacilli 
substantially and the risk if infection is reduced remarkably after couple of 
weeks. (Maasilta & Salo 2007, 1-3.) 
 
The risk of an infection by TB is related to the infectiousness of the person with 
TB, the duration of exposure, the susceptibility of those exposed the proximity 
to the source person and the efficacy of air conditioning. The risk of infection in 
public places and transport is low, but it is possible during long, over eight-hour 
flights. (WHO 2008.) 
 
An individual who has good health, correct nutrition and sufficient hygiene is at 
a less risk of getting the infection (Ruutu & Soini 2007). Tuberculosis is 
connected usually with poverty, malnutrition, overcrowding, substandard 
housing and insufficient health care. An infectious person releases droplets by 
talking, coughing, sneezing, laughing, or singing which the victim inhales. Active 
disease is also possible by reinfection and activation of dormant bacteria. About 
10% of patients who are initially infected develop active tuberculosis. (Smeltzer 
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& Bare 2004, 532-533.) This tells that 90% remain healthy carriers for the rest 
of their life. Tuberculosis is a common disease especially in the Southern and 
Central Africa and Eastern Europe (Ruutu & Soini 2007). In Finland, the 
majority of TB patients is over 65 and has a reactivation of the disease. (Kinnula 
et al. 1997, 465.) However, it is coming more prevalent in all ages due to 
immigrants from high-prevalence countries (Figure 1.).  
 
FIGURE 1. Estimated prevalence of tuberculosis per 100,000 people in 2007, 
per country (WHO 2009.) 
 
 
 
 
As emerged tuberculosis infection usually does not happen instantly. If a person 
spends a lot of time with an infected person and inhales a lot of nuclei from her 
the risk of infection rises high. These people are mostly family members, 
colleagues or other patients. (Hautamäki 2002, 41; Smeltzer & Bare 2004, 533.) 
 
Immunocompromised individuals are even at a higher risk compared to healthy 
ones. An individual at higher risk can be a person having cancer, HIV-infection, 
organ transplantation or receiving prolonged high-dose corticosteroid treatment. 
Substance abusers and people without sufficient access to health care 
(homeless and poor), people with a co-existing disease such as diabetes, 
chronic renal failure, poor nutrition, malignancies and hemodialysis are at risk. 
Being a health care worker working with risk groups also exposes to the 
infection. (Smeltzer & Bare 2004, 533.) 
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5.3 Background and history 
 
The mycobacteria have probably always been present, perhaps ever since 
5000 B.C. Mycobacterium tuberculosis was discovered by a German physician 
Robert Koch, with his microscope in 1882. He prepared an extract called 
tuberculin from the bacteria. The purpose was to develop a vaccine but to his 
disappointment it was not useful. Nowadays tuberculin is used in diagnostics. 
(Kinnula et al. 1997, 463.) 
 
It was not until 1944 when an American biochemist and microbiologist Selman 
Waksman discovered streptomycin. In 1946 another milestone was reached 
when a Swedish chemist Jörgen Lehmann found another medicine called para-
amino salicylic acid. These two were the first effective medications to eliminate 
tuberculosis. (Kinnula et al. 1997, 463.) 
 
In Finland hospitals provided by the state were built from the mid 1800s. The 
care of patients with tuberculosis was still supported by the private sector at that 
time. Funds from the state for their treatment were granted since the 1930s and 
special sanatoriums were built for these patients. The very first sanatorium was 
build by the Finnish Medical Doctor association, Duodecim. Funds were 
collected from the citizens. (Hautamäki 2002, 39, 41.)  
 
The patients were temporarily isolated from the society and the units were very 
independent. Patients came from all ages and statuses. The sanatoriums 
offered education on disease control and health promotion. Treatments were 
fresh air, healthy food and surgical procedures. Patient hygiene and cleanliness 
were highly respected and valued. The results were generally positive and 
afterwards patients could return to their normal life; to work and to the society 
again. The sanatoriums were operated until the 1960s. The meaning of the 
sanatoriums was diminished in the 1940s due to better antibiotics and in the 
1960s it was general to receive the treatment at home. (Hautamäki 2002, 39, 
41-42, 53-54.) 
 
The isolation concerned also children whose parents were sick with 
tuberculosis. In most of the cases it was the mother who gave up her newborn 
baby to a so called “joulumerkkikoti” (a home for children of parents suffering 
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from tuberculosis). For the child that meant isolation from the family. The point 
in isolation was to reduce the risk of infecting the children by the parents. 
(Hautamäki  2002, 54.) 
 
Sending small children to the homes must have been hard for the mothers but it 
was inevitable from the point of view the society. More important than personal 
feelings was common good. (Hautamäki 2002, 55.) The last of these homes 
was closed in Tampere in 1973 (Teramo 2003). 
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6 TUBERCULOSIS TODAY 
 
 
Today tuberculosis is classified as generally hazardous infective disease which 
means that this disease is treated whether the patient is compliant or not. 
According to Finnish law the patient can be admitted to a hospital against her 
wishes for maximum of two months (Hautamäki 2002, 43). 
 
 
6.1 Prevalence of tuberculosis 
 
It was the year of 2003 when the WHO (the World Health Organization) took the 
step to declaring tuberculosis as a global emergency. The disease was out of 
control in several parts of the world. Approximately one third of the world’s 
population had got the infection and almost nine million people became sick 
with this disease every year. (The European Health Report 2002, 23-24.) In 
2008, an estimated 11.1 million people were living with TB, a prevalence rate of 
170 per 100 000 population (WHO 2010). Tuberculosis is curable but about 1.6 
million people die from TB and 8 million new cases are diagnosed. (The 
European Health Report 2002, 23-24.). Of the patients 95% are in the 
undeveloped countries. In principle, effective, low-cost treatment is available, 
but not everybody in need has the access to it. (Advocacy to Control TB 
Internationally 2007, 3.) 
 
Nearly one third of HIV patients are also been infected with tuberculosis. It has 
been estimated that more than two million people die each year from HIV and 
TB’s lethal combination, both of which speed the other’s process. The worst 
situation is in the sub-Saharan Africa. (Activity Report 2007, 14.) 
 
There are a lot of challenges for efficient control of tuberculosis. These are 
health sector reform, prevention of disease and control in the prisons and last 
but not least education of the health care professionals. There is a need for 
assistance from the international community and donors. The epidemic has to 
be put under control. (The European Health Report 2002, 26.)  
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In Finland in 2006, 293 new cases of TB were diagnosed. The prevalence was 
5.6 per 100 000 inhabitants the same year. Pulmonary tuberculosis cases there 
were 210 and the prevalence of this form of TB was 4.0. (Appendix 3.) To 
compare to situation in 2009, the number of TB cases was 411 and prevalence 
7,7 per 100 000 inhabitants. The majority (295) was pulmonary cases. (THL 
2009.)  
 
 
6.2 Drug-resistant tuberculosis 
 
When effective medications against tuberculosis were discovered they were 
used commonly and without strict observation. Some people interrupted the 
course of antibiotics or took insufficient dosages of the medications. Over the 
decades the mycobacteria developed resistance against these drugs. New 
medications have been discovered but mycobacterium tuberculosis has evolved 
as well.   
 
The drug-resistant (DR-TB) TB is caused  by mycobacteria tuberculosis that are 
resistant to at least one of the basal anti-tuberculosis drugs and possibly to 
others but it is still not referred as the multiresistant type (Rajalahti &Valve 
2007). The multidrug resistant TB (MDR-TB) is caused by mycobacteria 
tuberculosis that are resistant to at least isoniazide and rifampin. These two are 
the most important first-line medications. The third, life-threatening form of TB is 
called the extensively drug-resistant TB (XDR-TB). It is caused by mycobacteria 
tuberculosis that are resistant to isoniazide and rifampin and to any of the 
fluoroquinolones and at least one of the following second line anti-TB-drugs: 
amikacin, kanamycin or capreomycin. (Martinez 2008. 14-15.) At the highest 
risk of developing the multidrug resistance are the HIV-positive, homeless and 
institutionalized people (Smeltzer & Bare 2004, 535).  
 
The multidrug resistant tuberculosis is more difficult and nearly 100 times more 
expensive to cure compared to non-drug resistant form. The MDR-TB is a major 
problem especially in prisons and other long term care facilities. (The European 
Health Report 2002, 24.) WHO (2008) estimates there are almost half a million 
new cases of MDR-TB per year. The highest rate was recorded in Baku (the 
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capital of Azerbaijan) where close to a quarter of all new TB cases (22.3%) 
were reported as the multidrug-resistant type. Among new TB proportions of 
MDR-TB cases were 19.4% in Moldova, 16% in Ukraine (in Donetsk), 15% in 
the Russian Federation (in Tomsk Oblast), and 14.8% in Uzbekistan (in 
Tashkent). These rates are surpassing the highest levels of drug resistance 
published in the last WHO report in 2004. In China also, surveys suggest that 
MDR-TB is widespread. (WHO 2008.) 
 
A patient suffering from multiresistant tuberculosis is treated in strict isolation 
under supervision in a specialized hospital unit. The combination of four drugs 
(isoniazide, rifampin, pyrazinamide and ethamputol) is used to start the 
treatment and the medication is revised after knowing more about the resistant 
strain. (Mustajoki, Alila, Matilainen & Rasimus  2007, 125.) 
 
The extensive drug-resistant form XDR-TB has been identified worldwide but 
the highest levels are found in Asia and the countries of the former Soviet 
Union. For instance, when in the USA 4% of MDR cases met the XDR-criteria, 
in Latvia, one of the countries of the highest MDR rates the criteria was met by 
19% in 2000-2004. (WHO 2006.)  
 
XDR-TB poses a serious public health threat especially in countries with high 
rates of HIV and few health care resources. So, given the underlying HIV-
epidemic drug-resistant tuberculosis could have a severe impact on mortality in 
Africa even though population prevalence of drug-resistant TB appears to be 
low compared to Asia and Eastern Europe. (WHO 2006.)  
 
If the patient has developed resistance to isoniazide and rifampin, the recovery 
is unsure. The treatment for a resistant strain as mentioned above is expensive 
and time consuming (Maasilta 2008). In case the medications are failing to 
eliminate TB, the disease is becoming fatal. Mortality rate is 50-60% at this 
point, the same as before discovering the medications. (Kinnula et al. 1997, 
479.) 
 
In Finland drug-resistant TB is still relatively rare. According to Soini (2005) in 
1998-2004 5% of all mycobacterium tuberculosis cases were drug-resistant, of 
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which only 0,5% met the MDR-criteria. Drug effectiveness has been 
approximately 95 % within seven years. (Table 1.)  
Table 1. M. tuberculosis -strains drug-resistance and -effectiveness 1998-2004   
(Soini 2005.) 
1998 1999 2000 2001 2002 2003 2004 Total  
---  (%) --- 
All cases of M. 
TB  
Drug effective- 
ness 
 
DR 
MDR 
413 
 
 
398 
(96.4) 
 
15 
(3.6) 
2 
(0.5) 
402 
 
 
385 
(95.8)
17 
(4.2) 
   0 
(0.0) 
450 
 
 
427 
(94.9)
23 
(5.1)
 
2 
(0.4) 
406 
 
 
378 
(93.1)
28 
(6.9) 
4 
(1.0) 
383 
 
 
361 
(94.3)
22 
(5.7) 
3 
(0.8) 
357 
 
 
339 
(95.0) 
18 
(5.0) 
3 
(0.8) 
261 
 
 
249 
(95.4) 
12 
(4.6) 
0 
(0.0) 
2 672 
 
 
2 537 
(94.9) 
135 
(5.1) 
 
14 
(0.5) 
 
 
In 2009 in Finland MDR-TB was discovered in six patients (2% of all infected 
with TB) reflecting increasing immigration from high-prevalence-TB countries. 
Drug sensitiveness was 93% of all cases the same year. So far there have not 
been any XDR-TB cases. (THL 2010.) 
 
 
6.3 Prevention and treatment 
 
 
6.3.1 The BCG-vaccine 
  
People can be protected from TB by vaccinating and by giving prophylactic 
medication to people at risk. The BCG-vaccine (Bacillus Calmette-Guérin) 
developed to reduce the risk of tuberculosis contains a live strain of attenuated 
Mycobacterium bovis. The BCG is the oldest vaccine in the world still used 
today. First used in France in the 1920s, the vaccine has been used widely 
since 1950 on an international level. This vaccine does not actually protect from 
the infection or does it give full protection against a new infection but it prevents 
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its spreading in the body. There is evidence that the vaccine when administered 
correctly to neonates clearly reduces the risk of serious infection. (Ruutu & Soini 
2007; Kinnula et al. 1997, 480, 482; Hey 2006.) 
 
All vaccines have side effects and potential adverse effects. The BCG -vaccine 
produces a pimple at the site of vaccination often slightly enlarging the lymph 
nodes in the surrounding area. This pimple bursts and discharges after a few 
weeks, leaving a scar. This is a normal reaction to the vaccination. In 1-2 
children out of each 1,000 vaccinated, the BCG vaccine has caused abscesses 
on the groin lymph nodes. These abscesses appear 3-7 months after 
vaccination. This does not demand any special treatment or increase the risk of 
more serious harm. (THL 2009.) 
 
Adverse effects of BCG vaccination are remote infections arising far from the 
site of vaccination. Bone and or joint inflammation, skin infection and 
generalized BCG infection are included. These conditions have been diagnosed 
in 14 out of each 100,000 vaccinated children. Remote infections are treated 
using tuberculosis drugs. A small percentage of joint and bone inflammation 
caused by this vaccination may remain as permanent disorders. Infections 
appear on average 14 months after vaccination. (THL 2009.) 
 
  
BCG-vaccine should not be given to individuals allergic to any of the 
compounds in the vaccine. Contraindication is also fever. The vaccine should 
not be given to individuals who are on corticosteroids, are having 
immunosuppressive therapy (including radiotherapy), having malignant tumors 
or HIV-infection (including babies of HIV-positive mothers). The effect of the 
vaccine can be excessive and in this case general BCG-infection is possible. 
Areas that have high incidence of tuberculosis, vaccinating symptomless HIV-
patients is relevant according to the WHO. There is no clear evidence for how 
long the vaccine gives immunity against tuberculosis but there are indications of 
it’s weakening after ten years. (Pharmaca Fennica 2009.) 
 
The systematic BCG -vaccinations in Finland were launched in the 1940s. The 
BCG vaccine used for a long time in Finland, had to be discontinued in 2002, 
the manufacturer ceasing production. It had been discovered that the new 
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vaccine caused more side effects than the previous one. (THL 2009.) Since 
1.9.2006, the protocol has been to vaccine only babies at the risk groups. 
(Ruutu & Soini 2007; Kinnula et al. 1997, 480, 482.) 
 
 
6.3.2. Medications  
 
In Finland the standard treatment for tuberculosis is isoniazide (INH) and 
rifampin (RMP) for six months. The third medication for the first two months is 
often pyrazinamide (PZA). An alternative to pyrazinamide is ethamputol (EMB). 
The patient takes all the medications at the same in the morning. (Maasilta 
2009.) In case patient has tuberculosis induced meningitis the treatment is on 
average 12 months. The medical therapy may continue for 9-18 months if some 
of these drugs cannot be used because of side effects. (Rajalahti 2007.) For the 
patient all the medications for treating tuberculosis are free of charge in Finland 
(Maasilta 2009). 
 
Almost all medications have undesired side effects. This applies also to 
antituberculosis drugs. For instance isoniazide can induce rash, fever, seizures, 
irritability, pins and needles -sensation and liver reactions. For pins and needles 
sensations Heksavit (vitamin B6) is given prophylactic. Rifampin reduces the 
effect of certain medications (for instance warfarin) and even contraceptives 
loose some of their effect. These are important issues to tell the patient. Side 
effects with this drug can be digestive problems, rash, symptoms of the Flu-
syndrome and dyspnea. Feces, sweat, urine and even contact lenses will 
discolor to brownreddish. Pyrazinamide causes joint aches, skin reactions, 
digestive problems (anorexia), liver problems and sensitivity to light. One of the 
side effects can be gout. Ethamputol may pose a risk of optic neuritis and other 
side effects such as joint aches. Streptomycin is ototoxic and may contribute to 
renal failure. Skin reactions and fever are also common with this medication. 
(Rajalahti 2007; Maasalmi 2009; Matilainen & Lientola 2007, 123-125.) 
 
Extra medications are taken according to secondary symptoms (drug induced). 
For dyspnea salbutamol is recommended. Cough medication can be taken for 
cough symptoms. Sputum secretion can be treated with bromhexidine and 
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difenhydramine. For nausea metoclopramide is effective. If the TB -patient is on 
warfarin therapy, the dosage of anticoagulants is usually set higher. A diabetic 
can suffer from changes in blood sugar levels. (Rajalahti 2007; Maasalmi 2009; 
Matilainen & Lientola 2007, 123-125.) 
 
Multidrug resistant tuberculosis can be prevented by taking medications strictly 
according to doctor’s orders. However, if this is the case then the medical 
therapy is started with four antituberculosis drugs. The list of medications is 
revised after knowing more about the resistant strain. (Maasilta 2009.) 
 
TB chemoprophylaxis is medical therapy for the patient being exposed to TB. 
This method is widely used in the United States since Americans do not usually 
administer the BCG-vaccine. In most cases isoniazide is used regularly for six 
months. With this two thirds remain healthy. Hepatitis related to taking 
isoniazide is 1 % of all patients. The risk is higher with age. Other medications 
can be added. For immunosupressed persons the prophylaxis seems to work 
well but sometimes it needs to be continued for the rest of their life. People 
being exposed to TB, are re-examined in 6, 12 and 24 months. Of relapses 80% 
occur within two years. (Kinnula et al. 1997, 469, 480-481.) 
 
Before starting and during the medication therapy laboratory values are 
monitored at least on a monthly basis. These include values that concern blood, 
functions of the liver, pancreas and kidneys. Urineanalysis is standardly taken 
as well. Chest x-ray is taken before starting the treatment and after two and six 
months. It can be taken more often if the patient’s condition deteriorates. 
Sputum smears and cultures are monitored on a regular basis. The first and the 
most important task is to sort out whether the strain of TB is resistant to any of 
the most commonly used drugs. (Maasilta 2009.) 
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7 TUBERCULOSIS AND THE GYNECOLOGICAL PATIENT 
 
 
An important form of extra pulmonary tuberculosis in the need of gynecological 
and obstetrical consideration is urinary and especially genital tuberculosis. 
Genitourinary TB is often a late manifestation of an earlier symptomatic or 
asymptomatic pulmonary tuberculosis infection (Pasternak & Rubin, 2001; 
Langemeier 2007, 279). A latency period from 5 to even 40 years between the 
time of the initial infection and the expression of genitourinary TB may occur 
(Gibson, Puckett & Shelly 2004; Langemeier 2007, 279). There are factors 
known to increase the reactivation of this infection. Uncontrolled diabetes, 
leukemia, Hodgkin’s disease, acquired immunosufficiency syndrome and 
advanced age are included in the risks as well as treatment with corticosteroids 
or immunosupressants (CDC 2005; Langemeier 2007, 280).  
 
Urinary TB is almost asymptomatic at first. Some of the possible symptoms can 
be difficulties to urinate, nocturia and pelvic pain. Classical symptoms are 
aseptic pyuria, proteinuria and hematuria. (Kinnula et al. 1997, 472-475.) 
Primary infection of the female genital organs is most often hematogenous and 
very rarely possible from sexual contact (Gupta, Sharma, Mittal, Singh, Misra & 
Kukreja 2007, 136). 
 
Pregnancy is rare in the presence of genitourinary tuberculosis and may be 
complicated by spontaneous abortion or ectopic pregnancy (Khan, 
Chandramohan & MacDonald 2004; Langemeier 2007, 281). A warning sign for 
genitourinary TB is a history of recurrent Escherichia coli infection (Langemeier 
2007, 281). Genital tuberculosis in women is most often localized in the mucosa 
of the uterus and in the follicle tubes. It can be the reason behind abnormal 
menstruation or infertility. Nevertheless it is possible after the menopause as 
well. (Kinnula et al. 1997, 472-475.)  
 
Urine samples of three following mornings are examined. Ultrasound of kidneys 
and CT are used in diagnostic procedures (Kinnula et al. 1997, 472-475). In 
some cases radiography and intravenous urography can be helpful in 
investigating the extensiveness of the infection (Langemeier 2007, 281). A 
sample of menstrual blood or dilatation and curettage -sample is used for 
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bacteriological and histopathological examinations. An endoscopic examination 
(laparoscopy) is a possible sample collection tool as well. Irregular menstruation 
and ascites implicate cancer but surprisingly TB can be the reason behind these 
symptoms. (Kinnula et al. 1997, 472-475.) Surgery (total abdominal 
hysterectomy with bilateral salpingo-oophorectomy) is usually not 
recommended but may be required if the woman does not desire more children 
or she does not respond to medical treatment (Gupta & al. 2007, 137). 
 
The medical therapy is the same for genital or urinary TB as for pulmonary 
tuberculosis. In the worst cases urinary TB may lead to kidney failure and to 
destruction of the kidney. In the case of genital tuberculosis the worst outcome 
could be infertility as discussed before. (Langemeier 2007, 279.) 
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8 TUBERCULOSIS AND PREGNANCY 
 
 
8.1 Tuberculosis in pregnancy 
 
Pulmonary as well as extra pulmonary tuberculosis is possible during 
pregnancy. Lymphadenitis, a form of extra pulmonary tuberculosis has no 
adverse effect on the maternal and fetal outcome, whereas for instance 
intestinal, spinal, endometrial and meningeal TB are associated with an 
increased frequency of maternal disability, fetal growth retardation and babies 
with low Apgar scores. The management of this disease during pregnancy 
needs special attention. The maternal and fetal healths are both affected. 
Diagnosis with TB includes hazards such as radiotherapy and medications. 
Untreated tuberculosis sets both parties in jeopardy. (Khilnani 2003, 105-106.) 
The incidence of tuberculosis in pregnancy is on the increase in the developed 
countries as a result of immigrants (Ormerod 2001, 494). 
 
There is interaction between tuberculosis and pregnancy. A woman can have 
tuberculosis and then get pregnant or she may become infected during 
pregnancy. Some researches suggest that pregnancy is a risk factor for 
acquiring TB (Ormerod 2001, 494). Pregnancy alters the immune response and 
therefore unusual manifestations of tuberculosis appear more often than with a 
non-pregnant person. Particularly when associated with poor nutrition, 
immunodeficiency and/or coexisting disease TB may flare up. (Adhikari 2009, 
234; Arora & Gupta 2003.) In pregnancy the prevalence of tuberculosis is from 
0.3% to 1.9%. Pregnancy during TB infection may influence on the outcome of 
pregnancy. Gestation has been variously reported to worsen, to improve or 
have no effect on TB. This disease may in some cases get worse during 
pregnancy and even lead to miscarriage. (Davis, Seward & Marcy 1999, 761; 
Rigby 2000, 284.) 
 
In most cases, however, pregnancy does not change the course of acute 
tuberculosis nor does it pose a risk for reactivation of the disease. Nevertheless 
the pulmonary or extra pulmonary tuberculosis on pregnancy includes 
prematurity, low birth weight, miscarriage and perinatal death. These cases 
 26
were more common among pregnant women who were diagnosed late, had 
incomplete or irregular treatment or suffered from advanced disease. Obstetric 
morbidity is increased four fold and preterm labor nine fold if carrying mother 
was diagnosed late. (Pearlman, Tintinalli & Dyne 2003, 162.) 
 
The signs and symptoms of tuberculosis are mostly the same for a pregnant 
woman than for any other patient: cough, weight loss, fever, malaise, fatigue 
and hemoptysis. Nevertheless it is more likely to a pregnant woman to have an 
asymptomatic disease than for a non-pregnant person. The early diagnosis of 
tuberculosis is often postponed due to the fact that pregnant women are not 
likely to have a chest-x-ray to confirm the infection. This is why expectant 
mothers, who are in the risk group of having tuberculosis, should be targeted for 
screening. The safest test to be performed during pregnancy is the Mantoux 
test, also called the tuberculin skin test. If the test is positive, a chest x-ray 
should be taken with shielding. This procedure exposes the fetus to most 
minimal amount of radiation. (Pearlman et al. 2003, 162.) For not so long in 
Finland physicians diagnosing TB on a pregnant woman have used a blood test 
called IGRA (B-TbIFNg). It is a newly discovered immunological screening 
method where in patient’s blood sample is indicated TB antigens sensitive T-
lymphocytes. (Laboratoriokeskus, 2011.) 
 
 
8.2 Prevention before and during pregnancy 
  
Prevention of tuberculosis before and during pregnancy is of utmost 
importance. To remain healthy a pregnant woman needs to lead a healthy life. 
This means healthy eating habits, physical activity, moderate alcohol 
consumption (none during pregnancy) and tobacco-free life. Regular visits to 
maternity clinic are essential. In case a pregnant woman suspects to have been 
exposed to tuberculosis she must contact her health care provider for further 
examinations. An infective person can be anyone with active TB, a family 
member or a colleague.  
 
It is essential to give counseling to future and especially expectant mothers of 
the effects of tuberculosis. If a woman planning a pregnancy belongs to the risk 
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group or already has the infection she should be informed about the TB and its 
effects on pregnancy. Should there appear any of the symptoms a mother 
needs to be referred to a specialist. There are always risks to pregnancy, even 
with a healthy mother. With tuberculosis, risks should be acknowledged and 
take measures accordingly to the pregnancy, weeks of gestation and 
symptoms.  
 
It would be important to start screening TB from immigrants coming from high 
prevalence TB countries. Especially fertile adults and pregnant women could be 
targeted for screening and method could be the Mantoux test. Positive results 
should be referred to further examinations and persons with negative results 
could have an info meeting and a brochure to take home. In pregnant clients, a 
negative Mantoux test result should not lead to a BCG –vaccination, even 
though there is evidence that there are no side-effects to the fetus. However, 
the vaccine can be administered to the mother if the risk of infection is high in 
the area and if the benefits overrun the risks.  (Pharmaca Fennica 2009.) 
  
The four basic drugs to treat tuberculosis – isoniazid, rifampin, pyrazinamide 
and ethamputol – are all safe to use in pregnancy. They are not teratogenic to 
the fetus. Potentially ototoxic for the baby are streptomycin and 
aminoglycosides and should not be used. Instead, P-amino salicylic acid has 
been safe. Ethionamide and protionamide are teratogenic inducing premature 
labor and therefore not recommended. It is very important to remember that 
active tuberculosis in pregnancy must always be carefully treated. Untreated TB 
is more harmful than the drugs for the mother and the baby. (Toman & Frieden 
2004, 166.) 
 
  
8.3 Drug-resistant tuberculosis and pregnancy 
 
Perhaps one of the worst scenarios in tuberculosis in pregnancy is that the first 
line drugs are not effective against the disease. The second line drugs will be 
introduced but the pregnant woman should be informed about the risks to the 
fetus. In the early weeks of pregnancy physicians may propose the option of 
abortion to a woman diagnosed with drug-resistant TB. The reason behind this 
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is that the medications may be fetotoxic and or toxic for the pregnant woman as 
well. The side effects of the medications have not been studied enough during 
pregnancy. (Lessnau & Quarah 2003, 954.) 
 
In spite of all that, an abortion needs not to be the only option. It has been 
reported a case of a pregnant woman diagnosed with MDR-TB who refused an 
abortion, received the second-line drugs and delivered a healthy neonate. 
(Lessnau & Quarah 2003.) There are no existing guidelines for the treatment in 
pregnancy and it has been suggested that the abortion could be considered 
elective while treating a pregnant woman with drug-resistant TB. 
 
 
A Pregnant woman diagnosed with DR-TB in the third trimester is a case to be 
review by a team of medical professionals in order to start treatment in 
pregnancy or deliver the baby and then start the treatment on both parties. A 
pregnant woman with drug-resistant tuberculosis has an increased risk of 
neonatal complications, a disease with more extensive radiographic changes 
and longer sputum conversion times (Khilnani 2004, 106).  
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9 TUBERCULOSIS IN CHILDBIRTH 
 
 
 
9.1 Risks in childbirth 
 
An outbreak of tuberculosis is possible also close to childbirth. A woman 
diagnosed with TB late in pregnancy has to have the medical treatment started 
instantly. However, since the diagnosis is confirmed this close to delivery the 
medications are not yet effective to prevent infecting the medical personnel or 
the unborn baby. The staff in the delivery room as well as in the operating room 
must always be prepared since a pregnant woman with open TB infection may 
be admitted to hospital at day or at night. Normally, a pregnant woman 
diagnosed with TB is followed up by maternity clinic and the risks of infection 
are monitored. The childbirth is planned well and managed in isolation. (Kalvas 
2009.)  
 
Nakanishi, Moritaka and Ueda (2004) report a case of a 29-year-old pregnant 
woman diagnosed with tuberculosis. She was admitted to hospital at 35 weeks 
of gestation. The treatment was started with isoniazide, rifampin and 
pyrazinamide. After 21 days with chemotherapy a caesarian section was carried 
out. In this way the risks of infection were minimized.  
 
 
9.2 Protection and prevention against the infection 
 
Only those women giving birth that have pulmonary tuberculosis are potentially 
infectious. However after two weeks of treatment including rifampin and 
isoniazide the person is no longer considered infectious. The mother can then 
be allowed to give birth naturally. A small potential risk arises if the pregnant 
woman is diagnosed later than two weeks prior to birth and she is sputum 
smear positive for acid fast bacilli. A new threat arises if she has DR-TB. Risk 
factors for having this should be evaluated and molecular tests for rifampin 
resistance done. If resistance is diagnosed, the staff is to use dust mist fume 
masks and the mother is isolated in negative pressure ventilation room. 
(Ormerod, 2001, 496-497.)  
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As mentioned above a mother diagnosed with tuberculosis is a risk not just to 
the unborn baby but to the health care personnel and other patients as well. 
Adequate protection must be used. If the infection is in the lungs and in acute 
phase, the baby needs protection and later on prophylactic medication. The 
personnel in the delivery room are prepared to prevent further infection to other 
expectant mothers and staff members.  
 
A route of infection of the fetus before or during child birth is from aspiration of 
infected amniotic fluid to direct contact with mycobacterium induced cervicitis or 
endometritis (Ormerod, 2001, 497). Genital TB is so rare in Finland that there is 
no official protocol for how to manage delivery with a woman diagnosed with it.  
According to Palomäki (2009) a caesarian section could be useful in some 
cases if the infection is in the woman’s birth canal.  
 
The 29-year-old woman reported above returned to the tuberculosis ward after 
the caesarian section and ethamputol was added to her medication. The baby 
entered to the neonatal care unit after confirming negative tubercle bacilli in 
amniotic fluid. (Nakanishi et al. 2004.) 
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10 TUBERCULOSIS AND PUERPERIUM 
 
 
10.1 Congenital tuberculosis 
 
Pregnant women with TB expose their fetus to the infection. The progression 
from infection to disease is highest during the first year of life. It has been 
shown that mothers transmitting the disease all had pulmonary TB. (Adhikari 
2009, 235.) 
 
Congenital tuberculosis in neonates is potentially serious; however it is rare; 
fewer than 300 cases have been reported in the English literature. During 
pregnancy it is possible that tuberculosis may infect the placenta or the female 
genital tract. The infection may also be introduced hematogenously through the 
umbilical vein. Primary focus then develops in the liver involving the lymph 
nodes and the tubercle bacilli infect the lungs secondarily. On the other hand 
the fetus may be infected by aspiration or indigestion of amniotic fluid 
contaminated by genous dissemination of TB through placenta. (Khilnani 2004, 
106; Rigby 2000, 289.) 
 
Symptoms of congenital TB appear within two or three weeks postnatally. The 
signs of the disease are often non-specific. Respiratory distress and 
hepatosplenomegaly appear most often. Following symptoms are fever and 
lymphadenopathy. Abdominal distension, lethargy, irritability, ear discharge and 
skin lesions are possible as well. (Khilnani 2004, 107.) Investigations require 
specimens from different sites and they may have to be repeated. At first the 
tuberculin skin test may be negative, but within 4-6 weeks it becomes positive. 
Chest radiograph, CT, gastric aspirates, smears from the middle ear and bone-
marrow aspirates may indicate acid-fast bacilli (ASF) (Table 2). Manifestation of 
TB in a newborn may lead to the diagnosis of the disease in the mother. 
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Table 2. Investigations for tuberculosis in the newborn 
--------------------------------------------------------------------------------------------------------- 
 
The Mantoux test (Tuberculin skin test) 
Blood tests 
Chest radiograph 
Computerized tomography (CT) 
Three early morning gastric aspirates/washings  
Cerebrospinal fluid 
Induced sputum 
Gamma Interferone blood test (TB specific (TbIFNg) 
Bronchoscopy 
 
 
 
The mortality rate of congenital tuberculosis is high, reaching nearly 50 percent. 
The major causative factor is delayed diagnosis (Khilnani 2004, 107). Clinically, 
tuberculosis in the neonate simulates other congenital infections such as 
syphilis, cytomegalovirus or bacterial sepsis. The placenta should be examined 
and cultured for mycobacterium tuberculosis if there is any suspicion of this 
disease. (Ormerod 2001, 497.) 
 
 
10.2 Tuberculosis and breastfeeding 
 
The safety of breastfeeding is an important issue. Normally breast milk provides 
the best nourishment for a newborn. Breastfeeding promotes health and helps 
to prevent disease. This way the baby receives the first line immune defense 
from the mother. By nursing the baby it gives both - the mother and baby - a 
strong bond. Breastfeeding is encouraged but isolation is recommended if 
mother has infectious disease (Gibbs, Danforth, Karlan & Haney 2008, 293).
  
The first-line TB-drugs cross into breast milk in variable amounts. However, the 
amounts transferred to the infant are not usually significant. Consequently 
breastfeeding is not discouraged. Tuberculosis medications should be taken 
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preferably after breastfeeding and the next feed should be a bottle-feed. If the 
mother and baby are both on isoniazide medication it is possible that the drug 
reaches supratherapeutic doses and in that case bottle feeding is advised. 
Supplementary vitamin B6 should be given to the baby on isoniazide or if the 
mother is taking this same medication because deficiency of vitamin B6 can 
cause seizures in the neonate. (Khilnani 2004, 108.) 
 
Active tuberculosis infection should be immediately, effectively and carefully 
treated with a breastfeeding mother. Prophylactic medication is to be 
considered for babies born to mothers with active pulmonary outbreak (Khilnani 
2003, 105). The mother and baby may stay together despite the disease but the 
concentration of the anti-tuberculosis drugs in the breast milk is not sufficient to 
prevent or treat the infection in the baby (Pearlman et al. 2003, 162). The 
mother with open TB can still infect her baby transmitting TB by aerogenous 
route.  
 
 
10.3 Protecting the newborn from tuberculosis 
 
Perinatal tuberculosis occurs from airborne infection. The source can be own 
mother or family member or another infectious person the newborn has had 
close contact. (Ormerod, 2001, 497.) It is not recommended to give the BCG -
vaccine to a mother during the time she is lactating. On the other hand, the 
vaccine can and should be given to the mother if the infection risk is high in the 
area and the benefits overrule the risks. (Pharmaca Fennica 2009.) 
 
To protect the newborn from the infection, isolation from the mother can be 
considered if the outbreak is right after the birth. The treatment is started on 
both parties instantly and within two weeks after starting the medications the 
mother is considered no longer infectious. 
 
For a new mother the instructions regarding tuberculosis are following the same 
formula as for a pregnant mother. If the mother has now an outbreak of 
tuberculosis she should immediately consult her health care provider. In the 
case of pulmonary tuberculosis this is all-important since it affects the baby 
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immediately. This is of course due to the fact that mother and baby live side by 
side for the first months. Baby, being exposed to infectious tuberculosis on a 
daily basis, is at risk of developing the infection. For a successful outcome it is 
crucial to follow doctor’s orders carefully.  
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11 CONCLUSIONS AND DISCUSSION 
 
 
Tuberculosis used to be common in the Finnish population as far as the 1950s. 
The situation improved due to better care in the hospitals and new effective 
medications. TB used to be well-known among physicians and midwives to the 
late 1970s, but today being rarer, the symptoms of this disease are not well 
recognized or the disease suspected anymore. It would be crucial for midwives 
and student midwives to identify tuberculosis and especially infectious persons 
as early as possible.  
 
Tuberculosis is coming more prevalent. At least 1/3 of the world’s population 
have been infected, approximately 1,6 million dies because of it and eight 
million is diagnosed with TB. (The European Health Report 2002, 23-24.) In 
Finland also, TB is rising; in 2006 the number of new TB diagnoses was 293 
and in 2009 already 411 (THL 2009). TB is arriving to Finland with immigrants 
from high risk areas; Russia, Estonia, Latvia and Africa. It has been estimated 
that one in every five Russians has latent tuberculosis infection. 
 
Since tuberculosis is reawakening, international collaboration is essential to 
prevent spreading of the disease. Donations to undeveloped countries for TB 
control and prevention is an investment for the future. If the spreading of 
tuberculosis is limited also the battle against drug resistance is more controlled. 
International conferences are of great importance in training and educating 
medical personnel on TB. In the future there are problems needing to be solved. 
These are for instance the multi-drug resistant and the extensively drug-
resistant variations of TB infection and the lethal combination of tuberculosis 
and HIV-infection. New medications must be discovered and above all new 
preventative measures must be taken.  
 
Pharmacotherapy is efficient but resistant and extremely resistant strains and 
co-infection with HIV pose a new threat, for pregnant women as well. It is vital to 
contribute to research in order to find new medications against resistant strains 
of TB.  
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This bachelor’s thesis was prepared using authentic and generally acceptable 
international and national references. Ethics and professional courtesy was 
respected. Finnish references have been used to map the relevant data on TB 
in Finland. It has been of great importance to use the newest and updated data. 
 
This study concludes that of utmost importance is prevention of the disease, 
guidance, screening and vaccinations of risk groups. Immigrants from high risk 
areas should be screened by tuberculin skin test and people traveling in high 
risk areas should maybe be tested for tuberculosis on arrival back to Finland. 
Maternity clinics’ nurses and midwives have an important role in detecting, 
testing and screening for TB. All midwives working in pre-, peri- and postnatal 
care must know about tuberculosis. This applies to midwifery students as well. 
In midwifery education in Finland TB is discussed very shortly and thus there 
exists a great need of education on tuberculosis detection and prevention. 
Since Finland is receiving fertile immigrants from high risk TB-areas, midwives 
working here must know about TB and give counseling to these immigrants.  
 
Finding relevant information on TB is not easy. There is a lot of old and un-
updated data on the topic, and too little new research. Tuberculosis in 
gynecology and obstetrics has been researched but only few studies exist so 
far. Most of the references are international and written for physicians.  
 
The booklet offers an up-to-date package of essential information on TB for 
midwives and midwifery students.  The information is meant to help midwifes 
recognize and prevent spreading of tuberculosis and further on educate their 
patients; give the advice and guidance in Finnish as well as in English. 
 
Possibilities of further research on this field are unlimited. Studies could be 
conducted on congenital tuberculosis or tuberculosis with newborns. Research 
on tuberculosis and HIV co-infection during pregnancy and its prevention would 
be of great importance since it is a growing problem in the world today. 
Updating the booklet in the future is important as well. The booklet can be 
extended and updated according to new protocols.  
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APPENDIX 1. Tuberculosis inquiry and tuberculin skin test (Cox 2007.) 
 
SHARE WITH WOMEN 
 
What is Tuberculosis? 
Tuberculosis (TB) is an infection caused by bacteria. It usually affects the lungs, but it can also 
cause problems in other parts of the body. 
 
I Do Not Know Anyone with TB. Is it a Big Problem in the United States? 
TB is most common in Latin America, Asia, and Africa. Still, there are more than 10 million people 
in the United States with TB. Thousands of new cases of TB are reported every year. In the United 
States, more than 80% of all TB infections occur in persons who are members of racial or ethnic 
minority groups. 
 
What are the Symptoms of TB? 
The symptoms of TB are: 
● A bad cough that lasts 3 weeks or more 
● Pain in the chest 
● Coughing up blood 
● Feeling weak or tired 
● Loss of appetite 
● Chills, fever, or sweating at night 
We are lucky that we have medicines to cure TB now. But if a person who has TB does not take 
medicine, they can die. 
 
How is TB Spread? 
When a person who has TB breathes out, the bacteria go out into the air. People who breathe in the 
bacteria from the air into their lungs may become infected. TB is not spread by sharing food. 
 
Does Everyone who Breathes in the TB Bacteria Get Sick? 
No, most people do not get sick even if they become infected with TB. Some people will get latent 
TB. A person with latent TB has the bacteria in their body, but is not sick and cannot spread TB to 
others. A few people who breathe in the bacteria will become sick with TB. There is no way of 
knowing who will get sick and who will not. 
 
Is There a Vaccine to Prevent TB? 
In countries where TB is very common, small children may be given a vaccine to prevent severe TB. 
The vaccine is called Bacille Calmette-Guérin (BCG). It is not usually given in the United States. 
 
How Can I Prevent TB? 
You can avoid getting TB by not having close contact or spending long periods of time around 
people who are sick with TB. People who are at high risk for TB should be tested and treated if they 
have the disease. 
 
I Am Pregnant. Should I be Tested for TB? 
TB testing is safe in pregnancy, and testing is recommended if you are in one of the following high 
risk groups: 
● You have close contact with people who are sick with TB 
● You have HIV/AIDS 
● You inject illegal drugs 
● You live in a high-risk place (prison, mental institution, or homeless shelter) 
● You are a health care worker serving high-risk clients 
● You were born in a country that has a high rate of TB and you came to the United States in the last   
5 years 
● Your health care provider has advised you to be tested 
You can be tested even if you had the BCG vaccine (see chart on next page) when you were a child. 
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APPENDIX 2. Further measures based on chest x-ray  
                        (Rajalahti, I. &Valve, K. 2007.)             
 
 
   Chest x-ray 
No TB changes TB changes TB scars 
No symptoms Symptoms
*
Symptoms No symptoms 
Sputum smear x 3 
No further  Laboratory values^ 
measures Chest x-ray 
in 6 and 12 
months 
Consultation to 
Pulmonary ward + 
 
 
* Cough > 3 weeks, sputum smears, hemoptysis, weight loss, night sweats, 
dyspnea 
^ PVK, La, CRP, Alat, Afos (according to Tampere University hospital) 
+ Pulmonary ward KEI2 (TUH) physician  
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APPENDIX 3. Tuberkuloosin ilmaantuvuus sekä viljelyvarmistettujen tapausten 
osuus Suomessa vuosina 1995-2006 (THL 2007.) 
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1 TUBERCULOSIS 
 
 
Tuberculosis (TB) is an airborne disease caused by Mycobacterium 
tuberculosis and its most common form is the pulmonary one. The symptoms 
are dry, non-productive cough (early stage), sputum-like or bloody cough (later 
stage), increased coughing, chest pains, shortness of breath, local wheezing 
cough, general malaise, fatigue, anorexia, weight loss, night sweats and low-
grade fever. Symptom-free tuberculosis is also a possibility at an early stage.  
 
Diagnostics include a physical examination, complete medical history, 
tuberculin skin test, chest x-ray, sputum smear and culture. Further 
examinations are carried out at a specific clinic for pulmonary diseases where 
the patient is referred by a physician or a gynecologist. Patient who has an 
acute outburst of tuberculosis is to be treated in hospital in isolation.  
 
Tuberculosis is not especially infectious, only the pulmonary one is potentially 
infectious. Bacilli must be at least 10 000-100 000 pieces in the sputum smear. 
If only the culture is positive the risk is minimal. Efficient pharmacotherapy 
reduces the risk of infection and after couple of weeks person is no longer 
infectious.  
 
An infectious person releases droplets by talking, coughing, sneezing and the 
victim inhales them. Active disease is also possible by reinfection and activation 
of dormant bacteria. About 10% of patients who are initially infected develop 
active tuberculosis. Tuberculosis is a common disease especially in the 
Southern and Central Africa and Eastern Europe. 
 
Tuberculosis infection does not happen instantly and a person needs to spend a 
lot of time with an infected person. These people are mostly family members, 
colleagues or other patients. Substance abusers, homeless, poor, people with a 
coexisting disease (such as diabetes) and immunocompromised individuals are 
at a higher risk. Being a health care worker working with risk groups also 
exposes to the infection.  
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2 TUBERCULOSIS TODAY 
 
 
Today tuberculosis is classified as generally hazardous infective disease and 
is treated whether the patient is compliant or not. According to Finnish law 
person can be admitted to hospital against his wishes for maximum of two 
months. 
 
About one third of the world’s population has got the TB infection and almost 
nine million people fall sick every year. Of the patients 95% are in the 
undeveloped countries. In Finland in 2006 293 new cases of TB were 
diagnosed of which pulmonary cases were 210. To compare to situation in 
2009, the number of TB cases was 411. The majority (295) was pulmonary.  
  
 
The drug-resistant TB (DR-TB) is caused by mycobacteria tuberculosis that 
are resistant to at least one of the basal anti-tuberculosis drugs and possibly to 
others but it is still not referred as the multiresistant type.  
The multidrug resistant TB (MDR-TB) is caused by mycobacteria tuberculosis 
that are resistant to at least isoniazide and rifampin.  
The extensively drug-resistant TB (XDR-TB) is life-threatening form of TB. It 
is caused by mycobacteria tuberculosis that are resistant to isoniazide and 
rifampin and to any of the fluoroquinolones and at least one of the following 
second line anti-TB-drugs: amikacin, kanamycin or capreomycin.  
 
 
In Finland drug-resistant TB is still relatively rare. In 1998-2004 5% of all 
mycobacterium tuberculosis cases were drug-resistant, of which only 0,5% met 
the MDR-criteria.  
 
The BCG-vaccine (Bacillus Calmette-Guérin) is developed to reduce the risk of 
serious tuberculosis. It does not give full protection but prevents TB from 
spreading in the body. The vaccine gives immunity for approximately ten years. 
In Finland it is not routinely given to babies anymore because of low prevalence 
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of tuberculosis. Since 1.9.2006, the protocol has been to vaccine only babies at 
the risk groups. The BCG-vaccine should not be given to individuals allergic to 
any of its compounds, to individuals having immunosuppressive therapy or HIV-
infection. Contraindication is also fever or severe rash. Areas that have high 
incidence of tuberculosis, vaccinating symptomless HIV-patients is relevant. 
 
In Finland the standard treatment for tuberculosis is isoniazide (INH) and 
rifampin (RMP) for six months. The third medication for the first two months is 
often pyrazinamide (PZA). An alternative to pyrazinamide is ethamputol (EMB). 
The patient takes all his medications at the same in the morning. For the patient 
all the medications for treating tuberculosis are free of charge in Finland.  
 
 
 
All antituberculosis drugs have undesired side effects 
 
 
Isoniazide can induce rash, fever, seizures, irritability, pins and needles -
sensation and liver reactions. For pins and needles sensations vitamin B6 is 
given prophylactic.  
Rifampin reduces the effect of certain medications (for instance warfarin) and 
even contraceptives loose some of their effect. Digestive problems, rash, the 
Flu-syndrome and dyspnea may appear. Feces, sweat, urine and even contact 
lenses will discolor to brownreddish.  
Pyrazinamide causes joint aches, skin reactions, digestive problems, liver 
problems, sensitivity to light and even gout.  
Ethamputol may pose a risk of optic neuritis and cause joint aches.  
 
 
 
Before and during the medication therapy laboratory values (that concern 
blood, functions of the liver, pancreas and kidneys) are monitored on a monthly 
basis. Urine analysis is done as well. Chest x-ray is taken before starting the 
treatment, after two and six months and whenever needed. Sputum smears and 
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cultures are monitored regularly. The strain of TB is tested for resistance to any 
of the most commonly used drugs. 
 
 
 
3 TUBERCULOSIS AND THE GYNECOLOGICAL PATIENT 
 
 
A gynecological patient may suffer from genital or urinary tuberculosis which 
often are late manifestations of an earlier symptomatic or asymptomatic 
pulmonary TB infection. Uncontrolled diabetes, acquired immunoinsufficiency 
syndrome and advanced age are risks for reactivation. Pregnancy is rare in the 
presence of genitourinary tuberculosis and may be complicated by spontaneous 
abortion or ectopic pregnancy. 
 
Primary infection of the female genital organs is most often hematogenous and 
rarely possible from sexual contact. Genital tuberculosis is often localized in the 
mucosa of the uterus and in the follicle tubes. It can be the reason behind 
abnormal menstruation or infertility. Nevertheless it is possible after the 
menopause as well. A sample of menstrual blood, dilatation and curettage-
sample or laparoscopy is used for examinations.  
 
Urinary TB is almost asymptomatic at first but later symptoms can be 
difficulties to urinate, nocturia and pelvic pain. Classical symptoms are aseptic 
pyuria, proteinuria and hematuria. A warning sign is a history of recurrent 
Escherichia coli infection. Urinary TB may lead to kidney failure. Urine samples 
of three following mornings are examined. Diagnostics include ultrasound of 
kidneys, CT, radiography and intravenous urography.  
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4 TUBERCULOSIS AND PREGNANCY 
 
 
The incidence of tuberculosis in pregnancy is on the increase in the 
developed countries as a result of immigrants. In pregnancy the prevalence of 
tuberculosis is from 0.3% to 1.9%. Pregnant women exposed to infectious 
(sputum smear positive) Mycobacterium tuberculosis are called to a primary 
check-up and follow-ups to a local health center (APPENDIX 1).  
 
A woman can have tuberculosis and then get pregnant or she may become 
infected during pregnancy. Pregnancy alters the immune response and 
tuberculosis may appear more often than with a non-pregnant person, 
particularly when associated with poor nutrition, immunodeficiency and/or 
coexisting disease.  
 
Tuberculosis can get worse during pregnancy even leading to miscarriage. In 
most cases, however, pregnancy does not change the course of acute 
tuberculosis nor does it pose a risk for reactivation. Tuberculosis in pregnancy 
includes prematurity, low birth weight, miscarriage and perinatal death 
especially if women are diagnosed late. Intestinal, spinal, endometrial and 
meningeal TB is associated with an increased frequency of maternal disability, 
fetal growth retardation and babies with low Apgar scores.  
 
The symptoms of tuberculosis in a pregnant woman are: cough, weight loss, 
fever, malaise, fatigue and hemoptysis. They are also more likely to have an 
asymptomatic disease. The expectant mothers in the risk groups should be 
targeted for screening by the safe Mantoux test. If it is positive, a chest x-ray 
should be taken. 
 
Prevention of tuberculosis is important and regular visits to maternity clinic 
during pregnancy are essential. If a woman planning a pregnancy belongs to 
the risk group or already has the infection she should be informed about the TB 
and its effects on pregnancy. Should there appear any of the symptoms a 
mother needs to be referred to a specialist.  
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The four basic drugs to treat tuberculosis – isoniazid, rifampin, pyrazinamide 
and ethamputol – are all safe to use in pregnancy (are not teratogenic). 
Potentially ototoxic for the baby are streptomycin and aminoglycosides and 
should not be used. P-amino salicylic acid has been safe. Ethionamide and 
protionamide are teratogenic (inducing premature labor) and not recommended. 
Active tuberculosis in pregnancy must always be carefully treated. If left 
untreated, TB is more harmful than the drugs for both.   
 
 
 
5 TUBERCULOSIS IN CHILDBIRTH 
 
 
Pregnant woman diagnosed with TB is followed up by maternity clinic and 
the risks of infection are monitored. The childbirth is planned well and managed 
in isolation. If the TB diagnosis is confirmed close to delivery the medications 
are started but are not yet effective to prevent infecting the medical personnel or 
the unborn baby.  
 
Only those women giving birth that have pulmonary tuberculosis are 
potentially infectious. The mother can be allowed give birth naturally after two 
weeks of medical therapy. A risk arises if the pregnant woman is diagnosed 
later than two weeks prior to birth and she is sputum smear positive. The staff 
and other patients use dust mist fume masks and the mother is isolated in 
negative pressure ventilation. The baby needs protection and later on 
prophylactic medication.  
  
A route of infection of the fetus before or during child birth is from 
aspiration of infected amniotic fluid to direct contact with mycobacterium 
induced cervicitis or endometritis. Caesarian section can be useful in some 
cases if the infection is in the woman’s birth canal.  
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6 TUBERCULOSIS AND PUERPERIUM 
 
 
Pregnant women with TB expose their fetus to the infection. Progression from 
infection to disease is highest in the first year. Congenital tuberculosis in 
neonates is serious but rare. Tuberculosis may infect the placenta or the female 
genital tract or it can be introduced hematogenously through the umbilical vein. 
The fetus may be infected by aspiration or indigestion of amniotic fluid 
contaminated by TB through placenta. 
 
Symptoms are often non-specific and manifest within two or three weeks 
postnatally. First respiratory distress and hepatosplenomegaly appear and are 
followed by fever and lymphadenopathy. Abdominal distension, lethargy, 
irritability, ear discharge and skin lesions are possible as well.  
  
Investigations require repeated specimens from different sites. The tuberculin 
skin test may be negative first, but in 4-6 weeks it becomes positive. Chest 
radiograph, blood tests, sample of cerebral-spinal fluid, sputum, CT, 
bronchoscopy, gastric aspirates, smears from the middle ear and bone-marrow 
aspirates may indicate TB. The mortality rate is nearly 50 percent due to 
delayed diagnosis. Tuberculosis in the neonate simulates other congenital 
infections such as syphilis or bacterial sepsis. The placenta should be examined 
and cultured for mycobacterium tuberculosis if there is any suspicion.  
 
The concentration of anti-tuberculosis drugs in breast milk is not sufficient to 
prevent or treat the infection in the baby. Prophylactic medications are given to 
babies born to mothers with active TB. The first-line drugs cross into breast milk 
but the amounts are not significant and breastfeeding is encouraged. 
Medications should be taken after breastfeeding and the next feed should be 
from the bottle. If both are on isoniazide it is possible that the drug reaches 
supratherapeutic doses and then bottle feeding is advised. Supplementary 
vitamin B6 should be given to the baby on isoniazide or if the mother is taking 
this same medication because deficiency of vitamin B6 can cause seizures in 
the neonate.  
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Perinatal tuberculosis can occur from airborne infection from the mother. To 
protect the newborn, isolation from the mother can be considered if the 
outbreak is right after the birth. The baby is vaccinated and the treatment is 
started on both parties instantly. 
 
 
 
In conclusion 
 
For the future it is of great importance to be aware of TB and its co-infections. 
Tuberculosis has infected nearly one third of HIV patients. It has been 
estimated that more than two million people die each year from TB and HIV’s 
lethal combination, both of which speed the other’s process. The worst 
situations are in the sub-Saharan Africa.  
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APPENDIX 1 
 
 
FOLLOW-UPS OF PREGNANT WOMEN EXPOSED TO TUBERCULOSIS  
(HUS 2010) 
 
 
 
Pregnant women exposed to infectious (sputum smear positive) Mycobacterium 
tuberculosis are called to a primary check-up and follow-ups to a local health 
center.  
 
 
Primary check-up after exposure to TB 
 
* Anamnesis 
   - Symptoms of TB infection 
   - Time of exposure, BCG-vaccination, prior TB infection and treatment,            
immunosuppressive diseases and treatment          
* Clinical examination 
* Chest x-ray at the first check-up 
   - Symptomless pregnant women after 20th gestational week 
   - Symptoms-having pregnant women disregarding gestational week. 
 
 
Follow-ups routinely and in the third trimester 
 
* Routine follow-up: Chest x-ray in 6 and 12 months after exposure to TB 
* In the third trimester the chest x-ray is always taken - at least an x-ray one 
month prior to due date. In case the x-ray shows no indication of TB, no further 
measures is necessary in the hospital for the delivery. The maternity clinic 
always informs the hospital of the x-ray. 
 
 
If any indication of TB during pregnancy 
 
* Chest x-ray (disregarding gestational week), sputum smear and culture x3 
* Consult a specialist in pulmonary diseases for further measures 
 
 
The newborn is always given the BCG vaccination if belonging to a risk group. 
 
 
 
 
 
 
 
